Hydroxyamphetamine Hydrobromide

HCID 9377
ノート反応
部分構造検索類似構造を探す

基本情報

CAS
140-36-3
標準SMILES
Br.CC(N)Cc1ccc(O)cc1
InChIKey
RZCJLMTXBMNRAD-UHFFFAOYSA-N
分子式
C9H14BrNO
平均分子量
232.12 g/mol
単同位体質量
231.02588

名称と識別子

優先名称
Hydroxyamphetamine Hydrobromide
IUPAC
4-(2-aminopropyl)phenol;hydrobromide

名称と別名

HYDROXYAMPHETAMINE HYDROBROMIDE306-21-8ParedrinePredrolonHydroxyamfetamine hbrhydroxyamfetamine hydrobromideHydroxyamphetamine hbrDTXSID0045961Phenol, 4-(2-aminopropyl)-, hydrobromideNSC-6106559IG47SZ0EPhenol, 4-(2-aminopropyl)-, hbr
名称をさらに表示
beta-(p-Hydroxyphenyl)isopropylamine hydrobromideDTXCID8025961NSC61065Hydroxyamphetamine hydrobromide (USP)Hydroxyamphetamine hydrobromide [USP]RefChem:56591Hydrobromide, Hydroxyamphetamine206-181-4

データベース識別子

CAS
140-36-3、306-21-8
PubChem CID
9377
DTXSID
DTXSID0045961
ChEMBL
CHEMBL1200705
UNII
59IG47SZ0E
EC Number
206-181-4

物性

構造計算による物性

極性表面積
46.3 Ų
水素結合供与体数
3
水素結合受容体数
2
回転可能結合数
2
重原子数
12

安全と法規制

GHS分類

GHS Classification · 5 件

Danger

H300+H330 (33.3%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oral; acute toxicity, inhalation]；H300 (33.3%): Fatal if swallowed [Danger Acute toxicity, oral]；H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]；H315 (66.7%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (66.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H330 (33.3%): Fatal if inhaled [Danger Acute toxicity, inhalation]；H335 (66.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]；H336 (33.3%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]；H361fd (33.3%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity]；H373 (33.3%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P320, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 2 (33.3%)；Acute Tox. 4 (66.7%)；Skin Irrit. 2 (66.7%)；Eye Irrit. 2A (66.7%)；Acute Tox. 2 (33.3%)；STOT SE 3 (66.7%)；STOT SE 3 (33.3%)；Repr. 2 (33.3%)；STOT RE 2 (33.3%)

化学と産業

薬理情報

MeSH Pharmacological Classification · 2 件

Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

関連反応

2 件
反応記録を作成

化合物ノート

読み込み中…